Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticusR0052 andBifidobacterium longumR0175) in rats and human subjects

2010/10/26 by Michaël Messaoudi, Robert Lalonde, Nicolas Violle +9 · 45 citations
Biochemistry, Genetics and Molecular Biology · Agricultural and Biological Sciences · Medicine · #Gut microbiota and health #Probiotics and Fermented Foods #Gastrointestinal motility and disorders

paper · pdf · doi:10.1017/s0007114510004319

Abstract

In a previous clinical study, a probiotic formulation (PF) consisting of Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 (PF) decreased stress-induced gastrointestinal discomfort. Emerging evidence of a role for gut microbiota on central nervous system functions therefore suggests that oral intake of probiotics may have beneficial consequences on mood and psychological distress. The aim of the present study was to investigate the anxiolytic-like activity of PF in rats, and its possible effects on anxiety, depression, stress and coping strategies in healthy human volunteers. In the preclinical study, rats were daily administered PF for 2 weeks and subsequently tested in the conditioned defensive burying test, a screening model for anti-anxiety agents. In the clinical trial, volunteers participated in a double-blind, placebo-controlled, randomised parallel group study with PF administered for 30 d and assessed with the Hopkins Symptom Checklist (HSCL-90), the Hospital Anxiety and Depression Scale (HADS), the Perceived Stress Scale, the Coping Checklist (CCL) and 24 h urinary free cortisol (UFC). Daily subchronic administration of PF significantly reduced anxiety-like behaviour in rats (P < 0·05) and alleviated psychological distress in volunteers, as measured particularly by the HSCL-90 scale (global severity index, P < 0·05; somatisation, P < 0·05; depression, P < 0·05; and anger-hostility, P < 0·05), the HADS (HADS global score, P < 0·05; and HADS-anxiety, P < 0·06), and by the CCL (problem solving, P < 0·05) and the UFC level (P < 0·05). L. helveticus R0052 and B. longum R0175 taken in combination display anxiolytic-like activity in rats and beneficial psychological effects in healthy human volunteers.

Citations

• The Hospital Anxiety and Depression Scale

Cited by

• Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
• The microbiota-gut-brain axis as a key regulator of neural function and the stress response: Implications for human and animal health1,2
• Kynurenine pathway metabolism and the microbiota-gut-brain axis
• Gastrointestinal microbiota in children with autism in Slovakia
• A potential role for the gut microbiome in substance use disorders
• The Microbiota-Gut-Brain Axis
• The Gut–Brain Axis
• Defensive responses: behaviour, the brain and the body
• Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial
• Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial
• Role of gut microbiota in depression: Understanding molecular pathways, recent research, and future direction
• Probiotic supplementation can positively affect anxiety and depressive symptoms: a systematic review of randomized controlled trials
• The effect of alcohol withdrawal therapy on gut microbiota in alcohol use disorder and its link to inflammation and craving
• Multi-level analysis of gut microbiome extracellular vesicles-host interaction reveals a connection to gut-brain axis signaling
• Fecal microbiota transplantation‐based treatment protocol for chronic insomnia disorder: A randomized, double‐blind, placebo‐controlled trial
• The gut microbiota–brain axis in behaviour and brain disorders
• Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress
• Probiotic food consumption is associated with lower severity and prevalence of depression: A nationwide cross-sectional study
• Mind and gut: Associations between mood and gastrointestinal distress in children exposed to adversity
• Psychobiotics and the Manipulation of Bacteria–Gut–Brain Signals
• Brain-gut-microbe communication in health and disease. [europepmc]
• Consumption of fermented milk product with probiotic modulates brain activity. [europepmc]
• Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. [europepmc]
• The role of microbiome in central nervous system disorders. [europepmc]
• Gut microbes and the brain: paradigm shift in neuroscience. [europepmc]
• Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. [europepmc]
• Control of brain development, function, and behavior by the microbiome. [europepmc]
• Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. [europepmc]
• Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health? [europepmc]
• Effect of Probiotics on Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [europepmc]
• Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder. [europepmc]
• Interactions between the microbiota, immune and nervous systems in health and disease. [europepmc]
• The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists. [europepmc]
• The Microbiome and Host Behavior. [europepmc]
• The Gut Microbiota and Autism Spectrum Disorders. [europepmc]
• Anxiety, Depression, and the Microbiome: A Role for Gut Peptides. [europepmc]
• The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Disease-a Critical Review. [europepmc]
• Mechanisms of Action of Probiotics. [europepmc]
• Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials. [europepmc]
• Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. [europepmc]
• The progress of gut microbiome research related to brain disorders. [europepmc]
• The Microbiota-Gut-Brain Axis: From Motility to Mood. [europepmc]
• Tryptophan Metabolism and Gut-Brain Homeostasis. [europepmc]
• Gut microbiome-wide association study of depressive symptoms. [europepmc]
• Gut microbiota and its metabolites in depression: from pathogenesis to treatment. [europepmc]

Related

• Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial
• Probiotic-mediated modulation of gut microbiome in students exposed to academic stress: a randomized controlled trial
• Does isovaleric acid play a key role in the interaction between probiotics and antidepressants? A secondary analysis of a randomized clinical trial
• Probiotic food consumption is associated with lower severity and prevalence of depression: A nationwide cross-sectional study
• Brain-Gut-Microbiota Axis and Mental Health